Skip to main content
. 2020 Jul 9;10:11341. doi: 10.1038/s41598-020-68247-0

Figure 2.

Figure 2

In vitro sustained release profile of lidocaine (top) and prilocaine (bottom) from biopolymers (left) and hybrid nanofilms (right). Data mean ± S.D., n = 6, 37 °C. LDC  2.5% lidocaine, PLC 2.5% prilocaine, CHT  2% chitosan, PCT 2% pectin, CHT–PCT 2% chitosan-pectin, NLC nanostructured lipid carriers encapsulating 5% LDC–PLC.